Loblaw Companies received a C$225.00 price target from UBS Group, indicating a potential upside of 15.63%. The stock has a "Moderate Buy" rating, with analysts from TD Securities, Royal Bank of Canada, and others adjusting their price targets, reflecting a consensus target of C$197.00. Currently trading at C$194.58, Loblaw has a market cap of C$59.42 billion and operates major grocery and pharmacy brands across Canada.